Latest News

Print

Summitt plans to fight disease.

Dr. Joshua Grill, Director of the Katherine and Benjamin Kagan Alzheimer's Disease Treatment Development Program and Director of Recruitment and Education Core for the Mary S. Easton Center for Alzheimer's Disease Research at UCLA, was quoted in the August 24 Fox Sports Exclusive article: "Summitt plans to fight disease."

"Summitt plans to fight disease"

Print

Pat Summitt to keep coaching despite dementia diagnosis.

Dr. David Teplow, Professor of Neurology, Director of Biopolymer Laboratory, and the Interim Director of the Mary S. Easton Center for Alzheimer's Disease Research at UCLA, was quoted in the August 24 ABC News article: "Pat Summitt to keep coaching despite dementia diagnosis."

"Pat Summitt to keep coaching despite dementia diagnosis"

Print

Amyloid-blocking drug poised for approval for rare disease.

Dr. David Teplow, Professor of Neurology, Director of Biopolymer Laboratory, and the Interim Director of the Mary S. Easton Center for Alzheimer's Disease Research at UCLA, was quoted in the August 19 Alzheimer's Research Forum about amyloid-blocking drug poised for approval for rare disease.

"Amyloid-blocking drug poised for approval for rare disease"

Print

Taking steps to prevent memory loss.

Dr. Paul Thompson, Professor-in-Residence of Neurology and a member of the UCLA Laboratory of Neuro Imaging, was quoted in a July 25 Milwaukee Journal-Sentinel article about research suggesting physical activity may help combat memory loss in elderly people.

"Taking steps to prevent memory loss"

Print

Alzheimer's survey finds "considerable optimism."

Dr. John Ringman, Associate Professor of Neurology of the UCLA Mary S. Easton Center for Alzheimer's Disease Research, was quoted in a July 20 USA Today article about research showing that most people would want to get checked for Alzheimer's disease if they thought they were suffering from early symptoms.

"Alzheimer's survey finds 'considerable optimism'"